KAMI CRASS: Open Payments
NPI 1245982032 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $399
Food & beverage: $299Education: $100
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 2 | $120 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| HARMONY BIOSCIENCES LLC | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Inspire Medical Systems, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
Products named: ACTHAR, NUCALA, WAKIX, INSPIRE, DUPIXENT, WINREVAIR, TRELEGY ELLIPTA, Prolastin-C Liquid.
Industry payments across MT — which companies pay providers there.
